MGMT testing-the challenges for biomarker-based glioma treatment.

Wick W, Weller M, van den Bent M, Sanson M, Weiler M, von Deimling A, Plass C, Hegi M, Platten M, Reifenberger G.

Nat Rev Neurol. 2014;10: 372 – 385